ARCHIVES

Pertuzumab Delays Progression In HER2-Positive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 8 | August 26, 2011

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI Last Month Are Listed

August 29, 2003

Merger Of Centers, Control Programs An Option, Upton Says; ACS To Fund New Prevention Centers

February 2, 1979

“Cancer Is a Disappearing Disease” and Other Controversies

January 3, 1986

NCCS Networker Volume 9 Issue 3, Summer 1995

June 12, 1995

In Brief: Von Hoff to Direct Arizona Cancer Center; American Health Foundation Appoints Nixon

April 23, 1999

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979